CD300LG Protein (Transcript Variant 4) (Myc-DYKDDDDK Tag)

Catalog No. ABIN2713626

This Recombinant CD300LG protein is produced in HEK-293 Cells.

Quick Overview for CD300LG Protein (Transcript Variant 4) (Myc-DYKDDDDK Tag) (ABIN2713626)

Target: CD300LG (TREM4) (Triggering Receptor Expressed On Myeloid Cells 4 (TREM4))

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Protein Characteristics: Transcript Variant 4

Purification tag / Conjugate: This CD300LG protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human CD300LG / CLM9 (transcript variant 4) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: CD300LG (TREM4) (Triggering Receptor Expressed On Myeloid Cells 4 (TREM4))

Alternative Name: Cd300lg,clm9

Background: Members of the CD300 (see MIM 606786)-like (CD300L) family, such as CD300LG, are widely expressed on hematopoietic cells. All CD300L proteins are type I cell surface glycoproteins that contain a single immunoglobulin (Ig) V-like domain (Takatsu et al., 2006 [PubMed 16876123]).[supplied by OMIM, Mar 2008].

Molecular Weight: 34

NCBI Accession: NP_001161794